DE1122947B - Verfahren zur Herstellung anabolisch wirksamer Carbonsaeureester des 1-Methyl-í¸-androsten-17ª-ol-3-ons - Google Patents
Verfahren zur Herstellung anabolisch wirksamer Carbonsaeureester des 1-Methyl-í¸-androsten-17ª-ol-3-onsInfo
- Publication number
- DE1122947B DE1122947B DESCH27643A DESC027643A DE1122947B DE 1122947 B DE1122947 B DE 1122947B DE SCH27643 A DESCH27643 A DE SCH27643A DE SC027643 A DESC027643 A DE SC027643A DE 1122947 B DE1122947 B DE 1122947B
- Authority
- DE
- Germany
- Prior art keywords
- methyl
- androsten
- anabolic
- esters
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims description 5
- 150000001733 carboxylic acid esters Chemical class 0.000 title claims description 3
- 238000002360 preparation method Methods 0.000 title claims description 3
- 230000001195 anabolic effect Effects 0.000 title description 15
- 150000002148 esters Chemical class 0.000 claims description 11
- 239000002243 precursor Substances 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 4
- 150000007933 aliphatic carboxylic acids Chemical class 0.000 claims description 4
- 150000008064 anhydrides Chemical class 0.000 claims description 3
- 150000004820 halides Chemical class 0.000 claims description 2
- 150000001735 carboxylic acids Chemical class 0.000 claims 2
- 125000001931 aliphatic group Chemical group 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 230000000694 effects Effects 0.000 description 14
- 230000001548 androgenic effect Effects 0.000 description 13
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 12
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- 229910052757 nitrogen Inorganic materials 0.000 description 6
- 229960002847 prasterone Drugs 0.000 description 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 5
- 239000011575 calcium Substances 0.000 description 5
- 229910052791 calcium Inorganic materials 0.000 description 5
- 230000029142 excretion Effects 0.000 description 5
- MNWFXJYAOYHMED-UHFFFAOYSA-M heptanoate Chemical compound CCCCCCC([O-])=O MNWFXJYAOYHMED-UHFFFAOYSA-M 0.000 description 5
- 210000001625 seminal vesicle Anatomy 0.000 description 5
- 201000010653 vesiculitis Diseases 0.000 description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 4
- XYGMEFJSKQEBTO-KUJXMBTLSA-N Clostebol acetate Chemical compound C1CC2=C(Cl)C(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](OC(=O)C)[C@@]1(C)CC2 XYGMEFJSKQEBTO-KUJXMBTLSA-N 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000032050 esterification Effects 0.000 description 4
- 238000005886 esterification reaction Methods 0.000 description 4
- MNWFXJYAOYHMED-UHFFFAOYSA-N heptanoic acid Chemical compound CCCCCCC(O)=O MNWFXJYAOYHMED-UHFFFAOYSA-N 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 229960003604 testosterone Drugs 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 229960004719 nandrolone Drugs 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-M octanoate Chemical compound CCCCCCCC([O-])=O WWZKQHOCKIZLMA-UHFFFAOYSA-M 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- DUCKXCGALKOSJF-UHFFFAOYSA-N pentanoyl pentanoate Chemical compound CCCCC(=O)OC(=O)CCCC DUCKXCGALKOSJF-UHFFFAOYSA-N 0.000 description 2
- 235000021075 protein intake Nutrition 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- FOTITZRWZUAVPH-UHFFFAOYSA-N 2-phenylpropanoyl chloride Chemical compound ClC(=O)C(C)C1=CC=CC=C1 FOTITZRWZUAVPH-UHFFFAOYSA-N 0.000 description 1
- ZRPLANDPDWYOMZ-UHFFFAOYSA-N 3-cyclopentylpropionic acid Chemical compound OC(=O)CCC1CCCC1 ZRPLANDPDWYOMZ-UHFFFAOYSA-N 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
- PDMMFKSKQVNJMI-BLQWBTBKSA-N Testosterone propionate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](OC(=O)CC)[C@@]1(C)CC2 PDMMFKSKQVNJMI-BLQWBTBKSA-N 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 229940030486 androgens Drugs 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- RVOJTCZRIKWHDX-UHFFFAOYSA-N cyclohexanecarbonyl chloride Chemical compound ClC(=O)C1CCCCC1 RVOJTCZRIKWHDX-UHFFFAOYSA-N 0.000 description 1
- MRKZAZMYXYSBDG-UHFFFAOYSA-N cyclopentyl propanoate Chemical compound CCC(=O)OC1CCCC1 MRKZAZMYXYSBDG-UHFFFAOYSA-N 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- WYVAMUWZEOHJOQ-UHFFFAOYSA-N propionic anhydride Chemical compound CCC(=O)OC(=O)CC WYVAMUWZEOHJOQ-UHFFFAOYSA-N 0.000 description 1
- 125000002755 pyrazolinyl group Chemical group 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229960001712 testosterone propionate Drugs 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 229940070710 valerate Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Priority Applications (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DESCH27643A DE1122947B (de) | 1960-03-26 | 1960-03-26 | Verfahren zur Herstellung anabolisch wirksamer Carbonsaeureester des 1-Methyl-í¸-androsten-17ª-ol-3-ons |
| CH604265A CH404656A (de) | 1959-12-05 | 1960-11-04 | Verfahren zur Herstellung von 1-Methyl-17a-alkyl- 1-androsten-17B-ol-3-onen |
| CH1237560A CH403750A (de) | 1959-12-05 | 1960-11-04 | Verfahren zur Herstellung von a,B-ungesättigten Ketosteroiden, die am B-ständigen Kohlenstoffatom eine Methylgruppe tragen |
| GB38871/60A GB965090A (en) | 1959-12-05 | 1960-11-11 | A process for the manufacture of ketosteroids and new ketosteroids |
| SE1176860A SE220239C1 (sv) | 1959-12-05 | 1960-12-05 | Sätt att framställa apha beta-omättade ketosteroider som innehaller en metylgrupp vid kolatomen i beta-läge |
| BE597814A BE597814A (fr) | 1959-12-05 | 1960-12-05 | Cétostéroïdesalpha,beta-non saturés, portant un groupe méthyl sur le carbone en position beta,et procédé pour leur préparation |
| SE388863A SE218983C1 (sv) | 1959-12-05 | 1963-04-08 | Sätt att framställa 1-metyl-17 a-metyl- och etyl 1-androsten-17 B-ol-3-oner |
| NL6600592A NL6600592A (enrdf_load_stackoverflow) | 1960-03-26 | 1966-01-17 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DESCH27643A DE1122947B (de) | 1960-03-26 | 1960-03-26 | Verfahren zur Herstellung anabolisch wirksamer Carbonsaeureester des 1-Methyl-í¸-androsten-17ª-ol-3-ons |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE1122947B true DE1122947B (de) | 1962-02-01 |
Family
ID=7430844
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DESCH27643A Pending DE1122947B (de) | 1959-12-05 | 1960-03-26 | Verfahren zur Herstellung anabolisch wirksamer Carbonsaeureester des 1-Methyl-í¸-androsten-17ª-ol-3-ons |
Country Status (2)
| Country | Link |
|---|---|
| DE (1) | DE1122947B (enrdf_load_stackoverflow) |
| NL (1) | NL6600592A (enrdf_load_stackoverflow) |
-
1960
- 1960-03-26 DE DESCH27643A patent/DE1122947B/de active Pending
-
1966
- 1966-01-17 NL NL6600592A patent/NL6600592A/nl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NL6600592A (enrdf_load_stackoverflow) | 1966-06-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2752695A1 (de) | Steroidester | |
| DE1543273C3 (de) | 7 alpha-Methyl-Delta hoch 5(16) -steroide der Oestranreihe und Verfahren zu deren Herstellung | |
| DE1801750A1 (de) | Von Prostaglandinen abgeleitete Verbindungen und Verfahren zu ihrer Herstellung | |
| DE1618980B2 (de) | In 17-stellung substituierte 11, 13beta-dialkylgon-4-en-3,17beta-diole und deren ester | |
| DE3336292C2 (enrdf_load_stackoverflow) | ||
| DE1122947B (de) | Verfahren zur Herstellung anabolisch wirksamer Carbonsaeureester des 1-Methyl-í¸-androsten-17ª-ol-3-ons | |
| AT245740B (de) | Verfahren zur Herstellung neuer Derivate des 1-Methyl-δ<1>-androstenolons | |
| DE1904586C3 (enrdf_load_stackoverflow) | ||
| DE1807585C3 (de) | 14,15beta-Epoxycardenolide, Verfahren zu deren Herstellung und diese enthaltende Mittel | |
| DE2109305C3 (de) | 20-Hydroxylierte 17 a - Methyl-19-nor-pregna-4,9diene, Verfahren zu deren Herstellung sowie Zwischenprodukte | |
| DE1593509C3 (de) | 1-Hydroxy-7alpha-methyl-östradlol-Derivate, Verfahren zu deren Herstellung sowie diese enthaltende Mittel | |
| CH493507A (de) | Verfahren zur Herstellung von 1B-Methyl-2,3a-methylen-steroiden | |
| AT258490B (de) | Verfahren zur Herstellung von neuen 1-Methyl- Δ<1> -5α-androsten-17β-ol-3-on-17-estern | |
| DE2137546C3 (de) | Verfahren zur Herstellung von 17alpha Athjnyl, Methyl und Vinyl 17beta Acetyloxysteroiden der Androstan bzw Ostranreihe | |
| DE1618977C (de) | Nitroostratnene und Verfahren zu deren Herstellung | |
| DE731071C (de) | Verfahren zur Darstellung von kernungesaettigten Acylverbindungen der Cyclopentanopolyhydrophenanthrenreihe | |
| DE1070631B (de) | Herstellung biologisch aktiver Cyclopentanohydirophenanthren - Verbindungen | |
| DE1618980C3 (de) | In 17-Stellung substituierte 11, 13beta-Dialkylgon-4-en-3,17beta-diole und deren Ester | |
| DE1593697C (de) | Verfahren zur Herstellung von 1 alpha Alkoxy , 1 alpha Alkenyloxy , 1 alpha Alkinyl oxy- oder 1 alpha Cycloalkyloxy 5 alpha steroiden | |
| DE1468632C (de) | öalpha Acetylthio 4 en 3 on steroide und Verfahren zu deren Herstellung | |
| DE1643020C (de) | 18 Methyl 19 nor 17alpha hydroxy progesterone, deren 17 Mono Ester Ver fahren zu ihrer Herstellung und diese enthaltendes Mittel | |
| DE1493164C3 (de) | lbeta-Halomethylandrostane und Verfahren zu ihrer Herstellung | |
| DE1793344A1 (de) | 2-Halogen-18-methyl-1-androstene | |
| DE1181214B (de) | Verfahren zur Herstellung von (1'-Alkoxy)-alkyl- und -cycloalkylaethern von 17ª‰-Hydroxysteroiden | |
| DE1493032B (de) | Verfahren zur Herstellung von 2 alpha, 3 alpha-Epithiosteroiden |